Загрузка...
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
In April 2010, the European Medicines Agency Committee for Medicinal Products for Human Use recommended approval of roflumilast, a selective phosphodiesterase 4 inhibitor, for the “maintenance treatment of severe chronic obstructive pulmonary disease (COPD, FEV(1) postbronchodilator less than 50% pr...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2915539/ https://ncbi.nlm.nih.gov/pubmed/20689641 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|